|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 11, 2008
doi: 10.1242/10.1242/dev.007047
1 James Graham Brown Cancer Center, Department of Ophthalmology and Visual
Sciences, University of Louisville Health Sciences Center, Louisville, KY
40202, USA.
2 Departments of Peiodontics, Endodontics and Dental Hygiene, Center for Oral
Health and Systemic Disease, University of Louisville School of Dentistry,
Louisville, KY 40292, USA.
3 Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan.
* Author for correspondence (e-mail: dcdean01{at}louisville.edu)
Accepted 16 October 2007
Overexpression of zinc finger E-box binding homeobox transcription factor 1 (Zeb1) in cancer leads to epithelial-to-mesenchymal transition (EMT) and increased metastasis. As opposed to overexpression, we show that mutation of Zeb1 in mice causes a mesenchymal-epithelial transition in gene expression characterized by ectopic expression of epithelial genes such as E-cadherin and loss of expression of mesenchymal genes such as vimentin. In contrast to rapid proliferation in cancer cells where Zeb1 is overexpressed, this mesenchymal-epithelial transition in mutant mice is associated with diminished proliferation of progenitor cells at sites of developmental defects, including the forming palate, skeleton and CNS. Zeb1 dosage-dependent deregulation of epithelial and mesenchymal genes extends to mouse embryonic fibroblasts (MEFs), and mutant MEFs also display diminished replicative capacity in culture, leading to premature senescence. Replicative senescence in MEFs is classically triggered by products of the Ink4a (Cdkn2a) gene. However, this Ink4a pathway is not activated during senescence of Zeb1 mutant MEFs. Instead, there is ectopic expression of two other cell cycle inhibitory cyclin-dependent kinase inhibitors, p15Ink4b (Cdkn2b) and p21Cdkn1a (Cdkn1a). We demonstrate that this ectopic expression of p15Ink4b extends in vivo to sites of diminished progenitor cell proliferation and developmental defects in Zeb1-null mice.
Key words: Zeb1, Epithelial-mesenchymal transition, Senescence, Transcription
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S. El-Naggar, Y. Liu, and D. C. Dean Mutation of the Rb1 Pathway Leads to Overexpression of mTor, Constitutive Phosphorylation of Akt on Serine 473, Resistance to Anoikis, and a Block in c-Raf Activation Mol. Cell. Biol., November 1, 2009; 29(21): 5710 - 5717. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, F. Ye, Q. Li, S. Tamiya, D. S. Darling, H. J. Kaplan, and D. C. Dean Zeb1 Represses Mitf and Regulates Pigment Synthesis, Cell Proliferation, and Epithelial Morphology Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5080 - 5088. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Sayan, T. R. Griffiths, R. Pal, G. J. Browne, A. Ruddick, T. Yagci, R. Edwards, N. J. Mayer, H. Qazi, S. Goyal, et al. SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer PNAS, September 1, 2009; 106(35): 14884 - 14889. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, L.-B. Ruest, and K. K. H. Svoboda Regulation of Epithelial-Mesenchymal Transition in Palatal Fusion Experimental Biology and Medicine, May 1, 2009; 234(5): 483 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chinnadurai The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors Cancer Res., February 1, 2009; 69(3): 731 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bracken, P. A. Gregory, N. Kolesnikoff, A. G. Bert, J. Wang, M. F. Shannon, and G. J. Goodall A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition Cancer Res., October 1, 2008; 68(19): 7846 - 7854. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, X. Peng, J. Tan, D. S. Darling, H. J. Kaplan, and D. C. Dean Zeb1 Mutant Mice as a Model of Posterior Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1843 - 1849. [Abstract] [Full Text] [PDF] |
||||